Cannot redeclare control with same name "grid_4_qv_meta_value_color"
Approved pharmaceutical formulations exist under separate distribution channels for type 2 diabetes (approved 2022), chronic weight management (approved 2023), and obstructive sleep apnea in adults with obesity (approved 2024)
This is critical information, since different types of cancer require different treatment
JAMA J Am Med Assoc
Methods This Phase II, multicentre, randomised, double-blind, parallel-group, placebo-controlled study, conducted in clinical research centres, assessed survodutide in participants aged 1875 years with type 2 diabetes, an HbA 1c level of 5386 mmol/mol (7.010.0%) and a BMI of 2550 kg/m 2 on a background of metformin therapy
Gallbladder inflammation or gallstones